poisar

Stocks · News reference

Archrock shares are trading lower after the company reported worse-than-expected Q2 financial results.

BenzingaBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Archrock, Inc. (AROC)

    Filed: 2026-09-28 AccNo: 0001389050-26-000034 Size: 139 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

  2. Zacks Investment ResearchZacks.Com

    Wall Street Analysts Look Bullish on Archrock Inc. (AROC): Should You Buy?

    While Wall Street analysts maintain a bullish average recommendation (1.67/5) on Archrock Inc. with 66.7% Strong Buy ratings, the article cautions investors against relying solely on broker recommendations. The Zacks Rank system, which focuses on earnings estimate revisions, has assigned AROC a Strong Sell rating (#5) due to a 4.4% decline in consensus earnings estimates over the past month, suggesting near-term downside risk despite positive analyst sentiment.